Navigation Links
Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
Date:4/21/2011

ent liquidity, anticipated cash flow from operations and expected capital needs, the Company is planning an annual payout ratio of 20 percent on adjusted net income.  The Company stated that it plans to increase the dividend meaningfully over time.

The Board also authorized repurchases of up to an additional $5 billion in Amgen common stock.  This is in addition to the approximately $2.2 billion remaining under its previous stock repurchase authorization.  The Company said it intends to return an average of approximately 60 percent of adjusted net income in the form of dividends and stock repurchases to stockholders through 2015.

"Our prospects through 2015 are strong and our strategy is clear," said Sharer. "A dividend and future share repurchases are important elements of our commitment to return significant value to shareholders."

During the meeting, Robert A. Bradway, president and COO, provided an update on Amgen's strategy to deliver Prolia and XGEVA worldwide sales of $3-$4 billion by 2015, to sustain the core business and invest in international expansion.

Bradway discussed the outlook for the erythropoiesis stimulating agents (ESA) franchise including regulatory, reimbursement and competitive issues. Bradway also reviewed the significant profitability improvement expected for Enbrel® (etanercept) following the expiry in late 2013 of the profit sharing agreement with Pfizer Inc.

Bradway highlighted the solid foundation for Prolia in the United States (U.S.) as global launches continue to build momentum. Anticipated upcoming catalysts include expanded reimbursement in the U.S. and new launches internationally. Bradway also highlighted the strong uptake of XGEVA.  

Bradway also discussed the Company's plans for continued international expansion resulting in over $1 billion in annual sales from existing products in new and emerging markets by 2015.  

Roger M. Perlmutter, M.D., Ph.D.
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
2. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
3. Amgen to Webcast 2011 Business Review Meeting on April 21
4. Amgen Announces Webcast of 2011 First Quarter Financial Results
5. Amgen Establishes Commercial Operations in Brazil
6. Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
7. Amgen Donates $1 Million to Help Japanese Disaster Victims
8. Amgen Completes Acquisition of BioVex
9. NBPTS and Amgen Foundation Join to Bolster Science Education
10. Amgen to Present at the Citi 2011 Global Healthcare Conference
11. CURE Magazine Teams Up With Amgen Oncology and Breakaway from Cancer® to Launch 2011 Extraordinary Healer Award for Oncology Nursing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and CARDIFF-BY-THE-SEA, Calif. , ... SRNE ;  Sorrento), an oncology company ... and Conkwest, Inc., a privately-held immuno-oncology company developing ... (NK) cell-line based therapy, announced today that the ... jointly develop next generation CAR-TNK™ (pronounced as "Car-Tank") ...
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/942kh3/micro_market ) ... Market Monitor: North American Dermatology Diagnostic Devices Market" ... http://photos.prnewswire.com/prnh/20130307/600769 Cosmetic surgeries ... resulted in fueling the overall demand of the ... these dermatology devices is to assist in identifying ...
(Date:12/19/2014)... Capnia, Inc. (NASDAQ: CAPN ... based on its proprietary Sensalyze™ Technology Platform for ... results for the third quarter and nine months ... completion of our initial public offering (IPO), we ... initiated CoSense® commercial launch," said Anish Bhatnagar, M.D., ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8
... March 31 We may introduce the first,"A"- Implant novelty from Austria: ... - two-part system, - extraordinary stability, ... of most reliable Zirconium oxide, - Manufactured for your ... After 4 years of research and technical development, ...
... in new super pill ORLANDO, Fla. and DENVER, ... Board: CONX) announced today that its AspirinWorks Test ... Study (TIPS) to help determine patients, response to ... the effect of combinations of aspirin, statin and ...
Cached Medicine Technology:Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09 2Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09 3
(Date:12/20/2014)... The Doctor’s Office Urgent Care of Paramus, New Jersey ... decade. They’ve treated over 40,000 patients while carrying out ... alternative to the Paramus area. , For 2015, the ... staff of top-notch board certified physicians: Christine Milosis MD, Sandra ... new doctors will work tirelessly to carry out The ...
(Date:12/20/2014)... New York, New York (PRWEB) December 20, 2014 ... ) continue to move forward in U.S. ... a new study which suggests that children treated ... prolactin, a hormone linked to breast development and ... Psychopharmacology, looked at 34 children and adolescents who ...
(Date:12/20/2014)... York, NY (PRWEB) December 20, 2014 The ... has caused quite a stir, not only in Hollywood, but ... on December 18th , the ripples of that attack are ... executives’ very jobs at risk. But they are not ... correspondences exposed could be in for some embarrassing times ahead, ...
(Date:12/20/2014)... 20, 2014 Developers of FCPX ... a new plugin for Final Cut Pro X entitled ... Volume 5 allows users to create hand drawn text ... Christina Austin, CEO of Pixel Film Studios. “TranSlice Volume ... while maintaining an easy to use interface.” , TranSlice ...
(Date:12/20/2014)... The Twin Cities DI Day is recognized as the ... 250 financial professionals come together each year to hear ... motivated to protect their clients and to be inspired ... challenges of disability. , On September 23rd, 2014, financial ... attend The 13th Annual Twin Cities DI Day where ...
Breaking Medicine News(10 mins):Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3
... change and the story behind Antarctica’s icy ambience, is unraveled ... clue. ,An element pretty unheard of and extremely ... clue to the University of Florida geologists in estimating the ... have opened up. This has happened obviously millions of years ...
... is being prompted by the Drug Manufacturer, Wyeth to ... drugs to treat menopause.// The drugs are made as ... ,Following Wyeth's recommendation to the FDA, the agency ... these custom-made treatments, and have requested the agency not ...
... can explain why men and women experience pain differently ... certain pain-relief drugs, reveals a new study conducted by ... for Behavioral Neuroscience (CBN). ,Although the study ... that similar differences occur in humans as well. The ...
... report by the Food and Agriculture Organisation (FAO) of the ... species said that domestic and wild birds spread the bird ... since the start of the avian influenza crisis (the end ... the transmission of the virus in the natural setting. ...
... as a clean up drive legalisation of drugs is in ... drugs to addicts// to help clean up the Downtown Eastside ... Sullivan a donation by an anonymous donor of $500,000 to ... reason and goal behind this whole exercise would be to ...
... flu in Ethiopia has been dismissed by health officials, following ... for the presence of the H5N1 virus. ,Officials ... organized on Thursday that no outbreak of bird flu has ... in several parts of the country. ,All necessary ...
Cached Medicine News:Health News:Gender Difference In Pain Experience Explained By Brain Diversity 2
BD Vacutainer® Specialty Tubes - Trace Element - Plastic...
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
Medicine Products: